Baxter International Inc. $BAX Stock: Murphy Pohlad Asset Management LLC Boosts Stake

Posted by Francis Steltz on Oct 24th, 2026

Murphy Pohlad Asset Management LLC grew its stake in shares of Baxter International Inc. (NYSE:BAX – Free Report) by 53.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 92,868 shares of the medical instruments supplier’s stock after acquiring an additional 32,467 shares during the period. Murphy Pohlad Asset Management LLC’s holdings in Baxter International were worth $2,229,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. BlackRock Inc. acquired a new stake in shares of Baxter International in the 2nd quarter valued at about $1,744,874,000. Pzena Investment Management LLC bought a new stake in Baxter International in the second quarter valued at about $1,392,098,000. Equity Investment Corp bought a new stake in Baxter International in the second quarter valued at about $146,815,000. Bank of America Corp DE acquired a new stake in Baxter International during the second quarter valued at approximately $132,993,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Baxter International in the 2nd quarter worth approximately $68,036,000. Institutional investors own 90.19% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Weiss Ratings lowered Baxter International from a “sell (d)” rating to a “sell (d-)” rating in a research report on Thursday, October 8th. UBS Group raised their price objective on Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a research note on Tuesday, July 28th. Wells Fargo & Company lifted their price objective on shares of Baxter International from $19.00 to $23.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Zacks Research upgraded shares of Baxter International from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 11th. Finally, Barclays initiated coverage on shares of Baxter International in a report on Wednesday, October 7th. They set an “underweight” rating and a $20.00 target price on the stock. One equities research analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Baxter International currently has an average rating of “Reduce” and an average price target of $21.73.

Check Out Our Latest Stock Report on BAX

Baxter International Stock Performance

Shares of NYSE:BAX traded down $0.33 during trading on Friday, hitting $25.32. 4,936,022 shares of the company traded hands, compared to its average volume of 6,154,588. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 1.39. The business’s fifty day moving average is $24.76 and its 200-day moving average is $22.15. The stock has a market capitalization of $13.09 billion, a price-to-earnings ratio of -12.23, a PEG ratio of 3.88 and a beta of 0.65. Baxter International Inc. has a one year low of $15.73 and a one year high of $30.00.

Baxter International (NYSE:BAX – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.19. The business had revenue of $2.96 billion for the quarter, compared to the consensus estimate of $2.80 billion. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%. The business’s revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the business posted $0.59 EPS. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. As a group, equities analysts predict that Baxter International Inc. will post 2.04 earnings per share for the current fiscal year.

Baxter International Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Friday, August 28th were issued a dividend of $0.01 per share. The ex-dividend date of this dividend was Friday, August 28th. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. Baxter International’s payout ratio is -1.93%.

Baxter International Profile

(Free Report)

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.